Zimmer Biomet Holdings Price to Sales Ratio 2010-2023 | ZBH
Historical PS ratio values for Zimmer Biomet Holdings (ZBH) over the last 10 years. The current P/S ratio for Zimmer Biomet Holdings as of April 25, 2024 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Zimmer Biomet Holdings P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2024-04-25 | 119.75 | 3.40 | |
| 2023-12-31 | 121.48 | $35.21 | 3.45 |
| 2023-09-30 | 111.80 | $34.64 | 3.23 |
| 2023-06-30 | 144.74 | $34.23 | 4.23 |
| 2023-03-31 | 128.22 | $33.79 | 3.79 |
| 2022-12-31 | 126.30 | $33.01 | 3.83 |
| 2022-09-30 | 103.37 | $32.78 | 3.15 |
| 2022-06-30 | 103.64 | $32.84 | 3.16 |
| 2022-03-31 | 125.89 | $32.73 | 3.85 |
| 2021-12-31 | 124.81 | $32.44 | 3.85 |
| 2021-09-30 | 143.52 | $29.73 | 4.83 |
| 2021-06-30 | 157.45 | $30.98 | 5.08 |
| 2021-03-31 | 156.50 | $28.54 | 5.48 |
| 2020-12-31 | 150.42 | $29.56 | 5.09 |
| 2020-09-30 | 132.68 | $34.10 | 3.89 |
| 2020-06-30 | 116.12 | $33.99 | 3.42 |
| 2020-03-31 | 98.13 | $37.71 | 2.60 |
| 2019-12-31 | 144.97 | $38.67 | 3.75 |
| 2019-09-30 | 132.74 | $38.56 | 3.44 |
| 2019-06-30 | 113.65 | $38.36 | 2.96 |
| 2019-03-31 | 123.01 | $38.53 | 3.19 |
| 2018-12-31 | 99.72 | $38.79 | 2.57 |
| 2018-09-30 | 126.10 | $38.77 | 3.25 |
| 2018-06-30 | 106.69 | $38.71 | 2.76 |
| 2018-03-31 | 104.17 | $38.47 | 2.71 |
| 2017-12-31 | 115.02 | $38.32 | 3.00 |
| 2017-09-30 | 111.39 | $38.04 | 2.93 |
| 2017-06-30 | 121.89 | $38.18 | 3.19 |
| 2017-03-31 | 115.71 | $38.31 | 3.02 |
| 2016-12-31 | 97.59 | $38.02 | 2.57 |
| 2016-09-30 | 122.67 | $38.34 | 3.20 |
| 2016-06-30 | 113.36 | $37.87 | 2.99 |
| 2016-03-31 | 100.21 | $34.92 | 2.87 |
| 2015-12-31 | 96.20 | $32.06 | 3.00 |
| 2015-09-30 | 87.89 | $29.00 | 3.03 |
| 2015-06-30 | 101.96 | $26.87 | 3.79 |
| 2015-03-31 | 109.48 | $27.04 | 4.05 |
| 2014-12-31 | 105.47 | $27.24 | 3.87 |
| 2014-09-30 | 93.32 | $27.34 | 3.41 |
| 2014-06-30 | 96.19 | $27.14 | 3.54 |
| 2014-03-31 | 87.41 | $27.07 | 3.23 |
| 2013-12-31 | 85.92 | $26.98 | 3.18 |
| 2013-09-30 | 75.57 | $26.47 | 2.86 |
| 2013-06-30 | 68.78 | $26.08 | 2.64 |
| 2013-03-31 | 68.85 | $25.61 | 2.69 |
| 2012-12-31 | 60.85 | $25.33 | 2.40 |
| 2012-09-30 | 61.56 | $24.81 | 2.48 |
| 2012-06-30 | 58.44 | $24.42 | 2.39 |
| 2012-03-31 | 58.20 | $23.94 | 2.43 |
| 2011-12-31 | 48.23 | $23.31 | 2.07 |
| 2011-09-30 | 48.28 | $22.76 | 2.12 |
| 2011-06-30 | 57.06 | $22.13 | 2.58 |
| 2011-03-31 | 54.65 | $21.44 | 2.55 |
| 2010-12-31 | 48.46 | $20.82 | 2.33 |
| 2010-09-30 | 47.24 | $19.72 | 2.40 |
| 2010-06-30 | 48.80 | $19.62 | 2.49 |
| 2009-12-31 | 53.37 | $18.88 | 2.83 |
| 2009-09-30 | 48.26 | $18.95 | 2.55 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $24.896B | $7.394B |
| Zimmer Biomet is a leading musculoskeletal healthcare company that designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $185.474B | 24.35 |
| Stryker (SYK) | United States | $128.161B | 31.78 |
| Boston Scientific (BSX) | United States | $106.966B | 34.07 |
| Medtronic (MDT) | Ireland | $106.730B | 15.11 |
| EssilorLuxottica (ESLOY) | France | $99.574B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.648B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.127B | 29.82 |
| ResMed (RMD) | United States | $27.032B | 27.03 |
| Terumo (TRUMY) | Japan | $25.476B | 35.98 |
| Baxter (BAX) | United States | $20.785B | 15.16 |
| Koninklijke Philips (PHG) | Netherlands | $19.474B | 15.53 |
| Insulet (PODD) | United States | $11.711B | 61.49 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.741B | 0.00 |
| Demant (WILYY) | Denmark | $9.943B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.934B | 23.64 |
| BellRing Brands (BRBR) | United States | $7.285B | 39.17 |
| Lantheus Holdings (LNTH) | United States | $4.470B | 11.54 |
| Haemonetics (HAE) | United States | $4.379B | 22.40 |
| Perrigo (PRGO) | Ireland | $4.232B | 12.10 |
| GN Store Nord (GNNDY) | Denmark | $3.937B | 25.50 |
| Envista Holdings (NVST) | United States | $3.485B | 13.26 |
| Prestige Consumer Healthcare (PBH) | United States | $3.482B | 16.46 |
| QuidelOrtho (QDEL) | United States | $2.730B | 9.91 |
| Neogen (NEOG) | United States | $2.679B | 25.77 |
| Green Thumb Industries (GTBIF) | United States | $2.630B | 83.33 |
| ICU Medical (ICUI) | United States | $2.357B | 17.58 |
| TG Therapeutics (TGTX) | United States | $2.161B | 699.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.928B | 0.00 |
| Owens & Minor (OMI) | United States | $1.895B | 18.19 |
| Verano Holdings (VRNOF) | United States | $1.790B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $1.780B | 0.00 |
| InMode (INMD) | Israel | $1.458B | 7.55 |
| LeMaitre Vascular (LMAT) | United States | $1.437B | 47.43 |
| National Vision Holdings (EYE) | United States | $1.388B | 43.24 |
| AdaptHealth (AHCO) | United States | $1.300B | 9.78 |
| Warby Parker (WRBY) | United States | $1.287B | 0.00 |
| AtriCure (ATRC) | United States | $1.115B | 0.00 |
| MacroGenics (MGNX) | United States | $0.982B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.899B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.779B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.712B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.693B | 14.98 |
| Evolus (EOLS) | United States | $0.666B | 0.00 |
| Quanterix (QTRX) | United States | $0.613B | 0.00 |
| Jin Medical (ZJYL) | China | $0.547B | 0.00 |
| Valneva SE (VALN) | France | $0.540B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.509B | 11.02 |
| PetIQ (PETQ) | United States | $0.487B | 18.17 |
| TerrAscend (TSNDF) | Canada | $0.478B | 0.00 |
| ZimVie (ZIMV) | United States | $0.430B | 26.35 |
| OraSure Technologies (OSUR) | United States | $0.421B | 6.96 |
| Biote (BTMD) | United States | $0.417B | 3.96 |
| Aurora Cannabis (ACB) | Canada | $0.393B | 0.00 |
| Surmodics (SRDX) | United States | $0.371B | 40.11 |
| Zynex (ZYXI) | United States | $0.361B | 41.59 |
| Viemed Healthcare (VMD) | United States | $0.314B | 31.11 |
| Cerus (CERS) | United States | $0.301B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.280B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.274B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.241B | 14.70 |
| Organigram Holdings (OGI) | Canada | $0.199B | 0.00 |
| Veru (VERU) | United States | $0.193B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.192B | 0.00 |
| Omeros (OMER) | United States | $0.176B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.163B | 0.00 |
| High Tide (HITI) | Canada | $0.160B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.159B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.134B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.130B | 65.20 |
| FitLife Brands (FTLF) | United States | $0.129B | 20.74 |
| InterCure (INCR) | Israel | $0.122B | 20.54 |
| Fonar (FONR) | United States | $0.102B | 8.80 |
| Cellectar Biosciences (CLRB) | United States | $0.099B | 0.00 |
| MariMed (MRMD) | United States | $0.097B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.096B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.088B | 0.00 |
| Brainsway (BWAY) | Israel | $0.084B | 0.00 |
| Safety Shot (SHOT) | United States | $0.081B | 0.00 |
| Chimerix (CMRX) | United States | $0.081B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.060B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.059B | 3.86 |
| Apyx Medical (APYX) | United States | $0.052B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.045B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.044B | 0.00 |
| ImmuCell (ICCC) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.039B | 15.04 |
| Bright Green (BGXX) | United States | $0.037B | 0.00 |
| Modular Medical (MODD) | United States | $0.035B | 0.00 |
| Exagen (XGN) | United States | $0.024B | 0.00 |
| Nephros (NEPH) | United States | $0.023B | 0.00 |
| Flora Growth (FLGC) | United States | $0.020B | 0.00 |
| Agape ATP (ATPC) | $0.020B | 0.00 | |
| FSD PHARMA (HUGE) | Canada | $0.018B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.017B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.013B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.010B | 72.54 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.001B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |